User profiles for Pierpaolo Alongi

Pierpaolo Alongi

Nuclear Medicine Unit - ARNAS Ospedale Civico, Palermo, Italy
Verified email at arnascivico.it
Cited by 1642

[HTML][HTML] Imaging features of adrenal masses

…, F Agnello, F Midiri, G Pecoraro, A Bruno, P Alongi… - Insights into …, 2019 - Springer
The widespread use of imaging examinations has increased the detection of incidental adrenal
lesions, which are mostly benign and non-functioning adenomas. The differentiation of a …

Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: An explorative study on machine learning feature …

P Alongi, A Stefano, A Comelli, R Laudicella… - European …, 2021 - Springer
Objective The aim of this study was (1) to investigate the application of texture analysis of
choline PET/CT images in prostate cancer (PCa) patients and (2) to propose a machine-…

Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT

P Alongi, M Picchio, F Zattoni, M Spallino… - European journal of …, 2016 - Springer
Purpose The purpose of our study was 1) to evaluate the diagnostic performance of 18F-fluorodeoxyglucose
(FDG) positron emission tomography (PET)/computed tomography (CT), 2) …

18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu's arteritis

…, F Fallanca, EM Baldissera, P Alongi… - European journal of …, 2017 - Springer
Purpose The object of this study was to assess whether 18 F-fluorodeoxyglucose PET/CT (FDG
PET/CT) provides novel information in patients with Takayasu’s arteritis (TA) in addition …

A cross-validation of FDG-and amyloid-PET biomarkers in mild cognitive impairment for the risk prediction to dementia due to Alzheimer's disease in a clinical setting

L Iaccarino, K Chiotis, P Alongi… - Journal of …, 2017 - content.iospress.com
Assessments of brain glucose metabolism (18F-FDG-PET) and cerebral amyloid burden (11C-PiB-PET)
in mild cognitive impairment (MCI) have shown highly variable performances …

[HTML][HTML] [68Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177Lu]DOTATOC PRRT: The “Theragnomics” Concept

…, D Deandreis, D Arico', M Ippolito, M Gaeta, P Alongi… - Cancers, 2022 - mdpi.com
Simple Summary The radiological response assessment of neuroendocrine tumors (NET) to
peptide receptor radionuclide therapy (PRRT) using [ 177 Lu]DOTATOC is still suboptimal …

[HTML][HTML] PSMA and choline PET for the assessment of response to therapy and survival outcomes in prostate cancer patients: a systematic review from the literature

P Alongi, R Laudicella, H Lanzafame, A Farolfi… - Cancers, 2022 - mdpi.com
Simple Summary Radiolabeled choline and PSMA PET have been largely tested in the initial
staging of prostate cancer and for biochemical recurrence. Moreover, diverse data are now …

[HTML][HTML] Somatostatin receptor PET/CT imaging for the detection and staging of pancreatic NET: a systematic review and meta-analysis

…, A Mirabile, AG Nappi, L Evangelista, P Alongi… - Diagnostics, 2020 - mdpi.com
We investigated the diagnostic performance of Somatostatin Receptor Positron Emission
Tomography/Computed Tomography (SSR-PET/CT) for the detection of primary lesion and …

Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis

…, G Iacolino, VR Giglio, F Lupo, P Alongi… - … Journal of Clinical …, 2020 - Taylor & Francis
In the last decades, an important role of cerebrospinal fluid (CSF) biomarkers for Alzheimer
disease (AD) diagnosis has emerged. The evaluation of the triad consisting of 42 aminoacid-…

[HTML][HTML] Feasibility on the use of radiomics features of 11 [C]-MET PET/CT in central nervous system tumours: Preliminary results on potential grading discrimination …

G Russo, A Stefano, P Alongi, A Comelli, B Catalfamo… - Current …, 2021 - mdpi.com
Background/Aim: Nowadays, Machine Learning (ML) algorithms have demonstrated
remarkable progress in image-recognition tasks and could be useful for the new concept of …